LabVantage Adds an SDMS to the 8.5 Edition of its LIMS Platform
Along with guaranteeing security and control against data loss or modification, the SDMS system works to automatically collect all relevant lab-generated data for use by laboratory staff.
LabVantage Solutions, a laboratory informatics solutions and services provider, announced that its newly released 8.5 edition of its laboratory information management system (LIMS) platform now offers a fully integrated scientific data management system (SDMS).
Along with guaranteeing security and control against data loss or modification, the SDMS system works to automatically collect all relevant lab-generated data for use by laboratory staff, a July 8, 2020 company press release said. The additional functions of the LabVantage SDMS include:
- Capturing externally generated data from instruments, data sources, incoming emails, and other file sources
- Reducing bottlenecks by deploying distributed file collectors
- Using a centralized LIMS-controlled file system, database, or Amazon web service (AWS) cloud for storage
- Finding and linking back to files for rapid access and restoration for further use
- Creating graphical Talend-based parsers to extract and process data.
“During these challenging times, we are especially proud to release LabVantage 8.5, which represents a major advance reflecting our commitment to making the advantages of digital transformation fully accessible to our customers,” said John Heiser, CEO of LabVantage, in the press release. “LabVantage 8.5’s fully integrated SDMS is specifically designed for the LabVantage platform and provides major benefits to laboratory managers, with the aim of making their operations more efficient, productive, and secure. Our user-friendly, all-in-one SDMS offers seamless, continuous data integrity. Importantly, it allows managers to secure all of their data, not just the final results.”
Source: LabVantage
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
